<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Six patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> treated with horse anti-human thymocyte globulin (ATG) and <z:chebi fb="3" ids="50113">androgen</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Four of these patients were only given ATG (ATGAMR), 16 mg/Kg/dose x 10 doses </plain></SENT>
<SENT sid="2" pm="."><plain>The remaining two cases received an infusion of maternal HLA-haploidentical marrow cells following ATG therapy </plain></SENT>
<SENT sid="3" pm="."><plain>One patient had a complete response, three had a partial response, one showed minimal improvement and two were non-responders </plain></SENT>
<SENT sid="4" pm="."><plain>The two patients who received the additional haploidentical marrow cells showed a hematologic recovery sooner than the ATG alone cases </plain></SENT>
<SENT sid="5" pm="."><plain>The toxicity of the ATG therapy was tolerable </plain></SENT>
<SENT sid="6" pm="."><plain>Long term follow up of there patients and further studies of this treatment in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with pediatric age group are under way </plain></SENT>
</text></document>